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Abstract: A set of new guaianolide derivatives (1-9) was obtained 
from Ludartin, Achalensolide and 11,13-Dihydroachalensolide by 
application of catalytic nitrene transfer reactions. Intermolecular 
nitrene C(sp3)—H insertions led to the amination of C-1, C-2 and C-
10 positions, while alkene aziridination was also observed under 
these reaction conditions. The antiproliferative activity of natural 
compounds and their derivatives was evaluated against a panel of 
human solid tumour cell lines. The results show that an increase in 
the biological activity was observed following amination at the C-2 
position of Ludartin, thereby demonstrating the interest of late-stage 
C—H amination to improve the bioactivity of natural products. 
The search for new bioactive compounds derived from natural 
products represents a successful strategy in drug discovery 
programs.[1] The derivatizations generally rely on functional group 
transformations, whereas modifications of C—H bonds were long 
neglected. However, functionalization of C—H bonds offers 
invaluable opportunities to reach a new molecular diversity. The 
last decade has witnessed the emergence of C—H activation 
reactions[2] that are now applied to complex natural compounds. 
The so-called late-stage C—H functionalization reactions are 
helpful to reach underexplored regions of the biologically relevant 
chemical space,[3] and to tune the pharmaco-dynamic and -kinetic 
properties of bioactive compounds.[4]  
Among the variety of C—H bond functionalization reactions, those 
that install a nitrogen functional group stand out.[5] Indeed, 80% of 
small-molecule drugs contain at least one nitrogen atom.[6]   
Moreover, nitrogen-containing functional groups are helpful to 
tune both the activity and the bioavailability of a bioactive 
compound.[7] Hence, the introduction of a new C—N bond in a 
single step is a challenge with relevant application in medicinal 
chemistry. In this context, catalytic iodine(III)-mediated nitrene 
transfer reactions, such as C(sp3)—H amination and alkene 
aziridination, have emerged as new synthetic tools for the 
preparation of potentially bioactive nitrogen-containing 
molecules.[5,8]   
Sesquiterpene lactones are important bioactive secondary 
metabolites found in several angiosperm plant families.[9] Most of 
these products bear alkylating groups, such as an α-methylene-
γ-lactone moiety, that are responsible for their biological 
activity.[10] Lipophilicity, molecular geometry, and electronic 
characteristics are other factors that may influence their biological 
response.[11] With the aim to tune their bioactivity, various 
sesquiterpene lactones derivatives have been prepared 
particularly via the transformation of the exocyclic double bond.[12] 
Thus, based on this observation and our expertise in nitrene 
chemistry,[13] we envisaged to derivatize sesquiterpene lactones 
by application of catalytic nitrene transfer with the main objective 
of functionalizing  new centers thereby accessing a new chemical 
space. Such changes was likely to influence the antiproliferative 
activities of the parent compounds. In this communication, we 
present the results of our investigations on natural guaianolides 
(Figure 1). 
 
Figure 1. Natural guaianolides for the study. 
Of particular interest for the present work were sesquiterpene 
lactones obtained from Stevia species. The cytotoxic Ludartin[14] 
can be isolated from Stevia yaconensis var. subeglandulosa 
Hieron.[15] On the other hand, Achalensolide  and 11,13-
Dihydroachalensolide have been isolated from the aerial parts of 
Stevia achalensis Hieron., an Argentinian endemic Asteraceae 
species.[16] The amination of these three natural guaianolides was 
investigated by application of protocols involving the use of 
Rh2(esp)2 (esp = a,a,a’,a’-tetramethyl-1,3-benzenedipropionic 
acid) as the catalyst, and two different sulfamates as nitrene 
precursors: trichloroethoxysulfonamide (TcesNH2) or 
phenylsulfamate (PhsNH2).[17] These conditions that involve the in 
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among the most efficient for catalytic intermolecular nitrene 
transfers.[18] Moreover, the regioselectivity of the C—H amination 
reaction can be controlled by the nature of the sulfamate.[19]  
We first investigated the application of catalytic intermolecular 
nitrene insertion reactions using the sulfamate TcesNH2 as the 
nitrene source (Scheme 1). It should be pointed out that the 
guaianolide starting material was the limiting component in all the 
reactions that occur with a good mass balance. Though the yields 
are low, all the reactions only afford the aminated products and 
recovered starting materials. 
Starting from Ludartin, the reaction afforded compound 1 (25%) 
that revealed a molecular formula of C17H20Cl3NO6S by HRESIMS. 
The NMR spectroscopic data suggested the presence of a new 
C—N bond at C-2 [δH 4.60 (d, J = 6.10 Hz, H-2), δC 57.2 (C-2)] 
corresponding to the introduction of a [2,2,2-
(trichloroethoxy)sulfonyl]amino group. The location of the C—N 
bond was confirmed by the HMBC correlation between the signal 
of H-2 and C-1 (δ 134.6), C-3 (δ 64.3), C-4 (δ 66.8), and C-10 (δ 
143.8) (see Figure S2 Supporting Information). The β orientation 
of the C—N bond was proposed based on the NOE observed 
between NH (δH 5.30) and H-6 (δH 3.62), possible only under 
these conditions (see Figure S4 Supporting Information). We 
propose that the complete diastereoselectivity may result from the 
presence of the epoxy group at C-3 and C-4 positions.[20]   
 
Scheme 1. Derivatives of natural guaianolides obtained by application of 
rhodium(II)-catalyzed intermolecular nitrene transfer with TcesNH2. 
The same reaction conditions were applied to Achalensolide 
affording compounds 2 (7%) and 3 (26%). Not surprisingly, the 
amination of the C-2 position was not observed as the C-H bond 
is deactivated by the adjacent electron-withdrawing carbonyl 
group. Compound 2 revealed a molecular formula of 
C17H20Cl3NO6S by HRESIMS. Inspection of the 1D and 2D NMR 
spectroscopic data indicated that compound 2 possesses an 
aziridine function involving C-11 (δC 49.6) and C-13 (δC 36.6). The 
1H NMR signals at δ 3.10 (H-13a) and δ 2.99 (H-13b) and the 
absence of resonances corresponding to the exocyclic double 
bond are in good agreement with the presence of an aziridine 
function at this position. The orientation of the aziridine was 
proposed based on the NOE observed between H-13a (δ 3.10) 
and H-6a (δ 2.88), (see Figure S7 Supporting Information). 
Compound 3 exhibited a molecular formula of C22H30Cl3NO8S by 
HRESIMS. The inspection of NMR spectroscopic data clearly 
showed that compound 3 results from the aziridine ring opening 
by pivaloic acid released from the iodine(III) oxidant, as previously 
reported by one of us.[21] The aziridine opening at C-13 was 
proposed based on the appearance of the signals corresponding 
to the pivaloyloxy group [δH 1.24 (s, H3-3’’), δC 177.4 (C-1’’), δC 
39.0 (C-2’’), and δC 27.2 (C-3’’)] and the upfield shifts of the CH2-
13 methylene signals from δC 36.6, δH 3.10, and δH 2.99 for 
compound 2 to δC 64.3, δH 4.53, and δH 4.39 for compound 3. The 
pattern of substitution at C-11 was confirmed through the 
correlation observed in the HMBC spectrum between H2-13 and 
C-12 (δ 172.7) and C-1’’ (δ 177.4) (see Figure S11 Supporting 
Information). In turn, NOE was observed between H-13a and H-6 
signals confirming the β orientation for the pivaloyloxy substituent 
(see Figure S12 Supporting Information). 
The amination reaction of 11,13-Dihydroachalensolide under 
these conditions afforded the sole compound 4 with 5% yield. 
Analysis of the NMR spectra showed the disappearance of one 
methine from the substrate and the presence of a quaternary 
carbon at δ 70.1 assigned to the C-1 position. The location of the 
aminated substituent was confirmed by the HMBC correlation 
between the signal of C-1 and H2-2 (δ 2.84 and δ 2.34), H2-6 (δ 
2.91 and δ 2.74), H2-9 (δ 1.68 and 1.32), H-10 (δ 1.88), H3-14 (δ 
1.21), and H3-15 (δ 1.79) (see Figure S16 Supporting Information). 
As previously observed in the late-stage C(sp3)—H amination of 
natural products displaying tertiary centers,[17b,c] the reaction 
takes place stereospecifically at the C-1 tertiary position 
delivering product 4 with retention of configuration. We then 
applied the same reaction conditions with a different nitrene 
precursor, PhsNH2, known to favor the amination of tertiary C—H 
bonds (Scheme 2).[17c] All the reactions occur with a good mass 
balance affording only the aminated products and recovered 
starting materials. Ludartin afforded compound 5 (36%) that 
revealed a molecular formula a molecular formula of C21H23NO6S 
by HRESIMS. The similarity in the 1H and 13C NMR chemical 
shifts of compounds 5 and 1 indicated that they possess the same 
skeleton substitution pattern, and stereochemistry. The only 
differences between 5 and 1 were the signals corresponding to 
the phenylsulfonyl substituent. In addition to product 5, traces of 
a compound that revealed to be the aziridine 6, were also isolated. 
 
Scheme 2. Derivatives of natural guaianolides obtained by application of 
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For Achalensolide, compound 7 (10%) and compound 8 (16%) 
were obtained. As previously proposed in the case of compound 
3, 7 is likely the result of an alkene aziridination at the C-11/C-13 
double bond followed by a ring opening by pivaloic acid. The 
same characteristic signals as those described for 3 were 
observed: the absence of the signals corresponding to the 
exocyclic double bond, the presence of the signals of the 
pivaloyloxy group, the chemical shift of the CH2-13, the HMBC 
correlations between H2-13 and C-12 at δ 172.5 and C-1’’ at δ 
177.7, and the NOE observed between H-13b and H2-6 at δ 3.09 
and δ 2.49 (see Figure S27 Supporting Information). Compound 
8 showed a molecular formula of C21H23NO6S by HRESIMS. NMR 
data analysis suggested the presence of the aminated substituent 
at C-10 position by the following evidence: the disappearance of 
the signal corresponding to the methine group at C-10, the 
change in the multiplicity of the H3-14 (δH 1.13) from doublet to 
singlet, and the presence of a signal corresponding to a 
quaternary carbon at δ 60.5. 
Compound 9 (17%) derived from 11,13-Dihydroachalensolide 
under the same reacting conditions. The HRESIMS of 9 showed 
a molecular ion corresponding to a molecular formula of 
C21H25NO6S. Its 1D and 2D NMR spectroscopic data indicated 
that compound 9 was closely related to compound 4, indicating 
the presence of the aminated substituent at C-1 (Table 2). The 
only differences between 9 and 4 were the signals corresponding 
to the phenylsulfonyl substituent. As in the case of 4, the reaction 
proceeded stereospecifically with retention of configuration at the 
tertiary site. 
Considering the antiproliferative activity shown by several 
sesquiterpene lactones,[22] Ludartin, Achalensolide, 11,13-
Dihydroachalensolide, and their derivatives (1,3-9) were 
evaluated towards six representative human solid tumor cell lines 
(A549, HBL-100, HeLa, SW1573, T-47D, and WiDr). The amount 
of derivative 2 obtained was insufficient to carry out the bioactivity 
tests. The antiproliferative effect was studied using the SRB 
assay.[23] Table 1 shows the results expressed as 50% growth 
inhibition (GI50) values.[24] The anticancer drug cisplatin was used 
as a reference compound. 
Viewed as a whole, these results allowed classifying the 
compounds into three groups. A first group, comprising 
Achalensolide and Ludartin derivatives 1 and 5, caused 
significant growth inhibition (GI50 <10 µM in all cell lines). The 
second set of compounds, including Ludartin and derivatives 3, 6, 
and 8 exhibited moderate activity (GI50 in the 10-40 µM range). 
The third group, containing 11,13-dihydroachalensolide and 
derivatives 4, 7, and 9 failed to show growth inhibition. Although 
8 is slightly less active than 1 and 5, the results tend to indicate 
that the presence of an exocyclic methylene group conjugated 
with the γ-lactone is crucial for the activity, confirming the role of 
this motif in the antiproliferative response. This is in agreement 
with previous reports where the modification of this functionality 
resulted in the loss of the bioactivity.[25] 
A significant increase in potency was detected in the aminated 
derivatives 1 and 5 of Ludartin. The substitution at C-2 position 
led to the generation of compounds more potent than their 
precursor and even somewhat more active than the cisplatin 
positive control. However, with respect to Achalensolide, the 
introduction of the same substituents at C-10 did not show a 
significant change in the antiproliferative activity. These results 
confirm that the introduction of a nitrogeneous functional group 
can positively contribute to the bioactivity, however, its impact 
depends on its position. The most potent compounds 
Achalensolide, 1 and 5 were selected as leads. Thus, they were 
tested against the human fibroblast cell line BJ-hTERT to 
determine their selectivity. The results indicate that the most 
potent compounds are at least 10 times more selective toward 
any of the rested tumor cell lines.
Table 1. In Vitro Antiproliferative Activity against Human Solid Tumor Cell Lines and a Human Fibroblast Cell Line.[a] 
Compound A549 HBL-100 HeLa SW1573 T-47D WiDr BJ-hTERT 
Ludartin 8.9 ± 1.2 17 ± 0.1 13 ± 1.7 10 ± 2.8 28 ± 1.5 17 ± 3.8 Nt 
Achalensolide 3.3 ± 0.03 6.0 ± 1.0 5.4 ± 1.5 4.9 ± 1.8 18 ± 1.6 4.5 ± 0.04 >100 
11,13-
Dihydroachalensolide 
>100 >100 >100 >100 >100 >100 Nt 
1 1.9 ± 0.4 1.8 ± 0.1 2.0 ± 0.02 2.0 ± 0.04 4.7 ± 0.2 2.7 ± 0.25 >100 
3 36 ± 4.8 50 ± 1.6 14 ± 2.0 36 ± 6.9 56 ± 6.6 47 ± 2.5 Nt 
4 >100 >100 >100 >100 >100 >100 Nt 
5 3.0 ± 0.5 3.2 ± 0.5 3.3 ± 0.4 2.5 ± 0.3 7.8 ± 2.0 3.8 ± 0.8 >100 
6 28 ± 5.1 22 ± 4.7 18 ± 2.3 21 ± 3.6 41 ± 3.4 27 ± 1.2 Nt 
7 >100 >100 >100 >100 >100 >100 Nt 
8 5.6 ± 0.05 13 ± 3.0 15 ± 2.0 6.8 ± 1.4 17 ± 0.02 12 ± 2.5 Nt 
9 >100 >100 >100 >100 >100 >100 Nt 
Cisplatin 4.9 ± 0.2 1.9 ± 0.2 1.8 ± 0.5 2.7 ± 0.4 17 ± 3.3 23 ± 4.3 14 ± 2.4 
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Table 2. Antiproliferative Activities (GI50 Values) using the SW1573 and SW1573/Pgp Cell Lines. [a] 
 -Verapamil +Verapamil 
 SW1573 SW1573/Pgp Rf SW1573 SW1573/Pgp Rf 
Achalensolide 3.1±0.1 5.1±0.5 1.6 3.7±0.7 3.5±0.2 1.0 
1 1.2±0.3 1.4±0.1 1.2 0.66±0.11 1.3±0.2 2.0 
5 0.64±0.08 1.1±0.1 1.8 0.96±0.11 1.4±0.1 1.5 
Paclitaxel 1.5±0.5 196±53 128 1.6±0.2 4.2±0.9 2.6 
Vinblastine 0.9±0.3 2051±682 2388 0.8±0.2 1.0±0.5 1.3 
[a] Values are given in µM and represent the mean values of at least two independent experiments ± standard deviation.  
Next, we studied the ability of the most active compounds to 
act as substrates for P-glycoprotein (P-gp), which is known to 
induce drug resistance in tumor cells by extruding toxins and 
xenobiotics out of the cell.[26] Achalensolide, 1 and 5 were 
evaluated for their possible interaction with P-gp. For this 
purpose, we tested the compounds against a wild-type cell line 
(SW1573) and its P-gp overexpressing variant 
(SW1573/Pgp),[27] in the presence or the absence of the known 
P-gp inhibitor verapamil (10 μM).[28] As reference drugs for this 
assay, we used the microtubule interacting drugs Paclitaxel 
and Vinblastine, which are known substrates for P-gp. The 
results, given as resistance factor (Rf), i.e. the ratio of GI50 
values in the P-gp overexpressing line to those in the wild type 
cell line, are shown in Table 2. Achalensolide, compounds 1 
and 5 all show low Rf values, denoting no effect of P-gp on 
their biological activity. Overall, the results indicate that the test 
compounds are not substrates for P-gp. 
In conclusion, this exploratory study highlights that late-stage 
C—H functionalization reactions are useful tools to tune the 
bioactivity of natural products. Application of rhodium-
catalyzed nitrogen-atom transfer reactions allowed us to 
explore a new biologically relevant chemical space with the 
isolation of 9 new derivatives from naturally occurring 
sesquiterpene lactones. These reactions proved to be useful 
for accessing, in one step, functionalized derivatives at 
positions tedious to modify by conventional synthetic methods. 
Particularly, tertiary and allylic positions were preferentially 
aminated, but the study also underscores the influence of the 
nitrene precursors on the chemoselectivity of the C—H 
amination reaction.  Importantly, this strategy has allowed the 
isolation of C—H aminated products that display improved 
antiproliferative activities when compared to those of the 
parent natural product. The combination of an interesting 
antiproliferative activity on cancer cell lines with the absence of 
extrusion by P-gp could make the evaluated molecules 
promising starting points for further development. Work is in 
progress to this end as well as to apply catalytic nitrene 
transfers to other natural products. 
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Application of rhodium(II)-catalyzed intermolecular nitrene transfers to naturally-occurring guaianolide compounds led to isolate nine 
new derivatives that possess an amino functional group at C-1, C-2, C-10, C-11 and/or C-13 positions. The relevance of late-stage C-
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